Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 8, 1999, Pages 561-571

  Kurioka, T ^a   Yunou, Y ^a   Harada, H ^a   Kita, E ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; COTRIMOXAZOLE; FOSFOMYCIN; KANAMYCIN; NORFLOXACIN; VEROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BRAIN DISEASE; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA; FECES ANALYSIS; GRAM NEGATIVE INFECTION; HEMOLYTIC UREMIC SYNDROME; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION;

AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; FOSFOMYCIN; KANAMYCIN; MICE; MICE, INBRED C57BL; NORFLOXACIN; PROTEIN-ENERGY MALNUTRITION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SHIGA TOXINS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032737310     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050348     Document Type: Article

References (31)

1. 1. Upadhyaya K, Barwick K, Fishaut M, Kashgarian M, Siegel NJ: The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics (1980) 65:115-120
2. 2. Karmali MA, Steele BT, Petric M, Lim C: Sporadic cases of haemolytic uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet (1963) i: 619-620
3. 3. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H: The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. Journal of Infectious Diseases (1985) 51:775-782
4. 4. Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, Oishi T, Joh K, Oikawa T, Muramatsu Y, Ogawa Y, Akashi S: Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatrica (1993) 82:454-458
5. 5. Butler T, Islam MR, Azad MAK, Jones PK: Risk factors for development of hemolytic uremic syndrome during shigellosis. Journal of Pediatrics (1987) 110:894-897
6. 6. Ostroff SM, Kobayashi JM, Lewis JH: Infections with Escherichia coli O157:H7 in Washington State: the first year of statewide disease surveillance. JAMA (1989) 262:355-359
7. 7. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D, Blake PA: Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. Journal of Pediatrics (1990) 116:544-551
8. 8. Al-Qarawi S, Fontaine RE, Al-Qahtami MS: An outbreak of hemolytic uremic syndrome associated with antibiotic treatment of hospital patients for dysentery. Emerging Infectious Diseases (1995) 1:138-140
9. 9. Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG: Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection (1992) 20:25-29
10. 10. National Institute of Health and Infectious Diseases Control Division, Ministry of Health and Welfare of Japan: Outbreak of enterohemorrhagic Escherichia coli O157:H7 infection. Infectious Agents Surveillance Report (1996) 174:180-181
11. 11. Takeda T, Yoshino K, Uchida H, Ikeda N, Tanimura M: Early use of fosfomycin for STEC O157 infection reduces the risk of hemolytic uremic syndrome. In: Kaper J, O'Brien A (eds): Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington DC (1998) pp 385-387
12. 12. Kurioka T, Yunou Y, Kita E: Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infection and Immunity (1998) 66:1726-1734
13. 13. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Kawai T: Endotoxin-inactivating activity in normal and pathological human blood samples. Infection and Immunity (1986) 53:294-297
14. 14. Yamai S, Obara Y, Nikkawa T, Shimoda Y, Miyamoto Y: Preservation of Neisseria gonorrhoeae by the gelatin-disk method. British Journal of Venereal Diseases (1979) 55:90-93
15. 15. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA (1993)
16. 16. Goto S, Dogasaki I, Kaneko Y, Ogawa M, Takita T, Kuwahara S: In vitro and in vivo antibacterial activity of fosfomycin. Chemotherapy (1975) 23:1653-1661
17. 17. Noda M, Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y: Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microbial Pathogenesis (1987) 2:339-349
18. 18. Weiser MM: Intestinal epithelial cell surface membrane glycoprotein synthesis. An indicator of cellular differentiation. Journal of Biological Chemistry (1973) 248:2536-2541
19. 19. Kahan FM, Kahan JS, Cassidy PJ, Kropp H: The mechanism of action of fosfomycin (phosphonomycin). Annals of the New York Academy of Sciences (1974) 235:364-386
20. 20. Moriguchi N, Yagi K, Yamamoto T, Yoshioka K, Kubo S: The drug sensitivity of enterohemorrhagic Escherichia coli and antibiotic treatment for hemorrhagic enterocolitis: from an outbreak of enterocolitis in Sakai city. Japanese Journal of Antibiotics (1997) 50:591-596
21. 21. Yanaginuma K, Murata S, Umemura K, Tomono N, Kikai S, Fujita M: Pharmacokinetics of intravenous preparation of fosfomycin sodium salt in the rabbit and the dog. Japanese Journal of Antibiotics (1978) 31:465-473
22. 22. Yanaginuma K, Hayasaka Y, Murata S, Umemura K: Behavior of fosfomycin calcium in the rat after oral administration. Yakuzaigaku (1975) 35:199-208
23. 23. Naide Y, Suzuki K, Kawasaki T, Oda T, Okoshi M: Clinical and laboratory evaluation of fosfomycin in treatment of urinary tract infections. Chemotherapy (1975) 23:1954-1959
24. 24. Ito T, Akino E, Hiramatsu K: Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis: effect of various antibiotics on extracellular release of verotoxin. Journal of the Japanese Association for Infectious Diseases (1997) 71:130-135.
25. 25. Kobayashi I, Muraoka H, Matsuzaki K, Saika T, Nishida M, Akita H, Iwata S, Satou Y, Sunagawa K: A mouse model of Escherichia coli O157:H7 infection for evaluation of antibacterial drugs: in vivo release of verotoxins and toxic effect on mice. Japanese Journal of Chemotherapy (1998) 46:112-118
26. 26. Nakata K, Tozu T, Hoshikawa Y, Sakai A, Tanaka N, Akashi T, Kanegasaki S: Suppressive effect of clarithromycin on the production of verotoxin by E. coli O157. Journal of the Japanese Association for Infectious Diseases (1997) 71:437-442
27. 27. Higami S, Kishimoto K, Kawamura T, Tsuruhara T, Isshiki G, Ookita A: Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak. Journal of the Japanese Association for Infectious Diseases (1998) 72:266-272
28. 28. Kita E, Sawaki M, Oku D, Hamuro A, Mikasa K, Konishi M, Emoto M, Takeuchi S, Narita N, Kashiba S: Suppression of virulence factors of Pseudomonas aeruginosa by erythromycin. Journal of Antimicrobial Chemotherapy (1991) 27:273-284
29. 29. Proulx F, Turgeon JP, Delage G, Lafleur L, Chicoine L: Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. Journal of Pediatrics (1992) 121:299-303
30. 30. Karch H, Goroncy-Bermes P, Opferkuch W, Kroll HP, O'Brien AD: Subinhibitory concentrations of antibiotics modulate amount of Shiga-like toxin produced by Escherichia coli. In: Adam D, Hahn H, Opferkuch W (eds): The influence of antibiotics on the host-parasite relationship II. Springer-Verlag, Berlin (1985) pp 239-245
31. 31. Karch H, Strockbine NA, O'Brien AD: Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiology Letters (1986) 141:141-145